Melodie Wilson Oldenburg Breast Cancer Symposium

Milwaukee, WI US
October 3, 2014

This educational activity will address the multidisciplinary management of breast cancer. Featured speakers are leaders in their respective of breast cancer. Featured speakers are leaders in their respective fields of breast cancer research and treatment who will provide up-to-date summaries of important and diverse topics pertinent to the multidisciplinary management of breast cancer.

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 3.5 hours of participation for continuing education for allied health professionals. 

Target Audience

  • Medical Oncologists
  • Radiation Oncologists
  • Surgical Oncologists
  • Residents and Fellows
  • Allied Health Professionals

Learning Objectives

At the conclusion of this symposium, participants will have improved awareness and understanding of:

  • The importance of multidisciplinary care in the management of breast cancer.
  • Options available to assess breast cancer margins intraoperatively in patients undergoing lumpectomy.
  • Post-lumpectomy and post-mastectomy radiation therapy approaches to the breast and chest wall. 
  • Surgical and radiation management options for node-positive breast cancer after lumpectomy and mastectomy.
  • Novel systemic therapy approaches for breast cancer, which comprise immunotherapy, targeted therapies including the PI3K/mTOR signaling pathway, and other modalities that may be used in conjunction with standard chemotherapy regimens, hormonal therapy, and targeted H2N therapy.
Additional information

CME Coordinator Contact Information

Name: 
Dana Schmidman
Phone Number: 
+1 (414) 805-5602
Course summary
Available credit: 
  • 3.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 3.50 Hours of Participation
    Hours of Participation credit.
Course opens: 
10/01/2014
Course expires: 
12/31/2014
Event starts: 
10/03/2014 - 7:30am
Event ends: 
10/03/2014 - 3:00pm
Cost:
$0.00
MCW Alumni Center
8701 Watertown Plank Road
Milwaukee, WI 53226
United States
William J. Gradishar, M.D.
Betsy Bramsen Professor of Breast Oncology & Professor of Medicine
Director, Maggie Daley Center for Women’s Cancer Care
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
 
Lee G. Wilke, M.D.
Professor of Surgery
Department of Surgery Director
University of Wisconsin Breast Center
University of Wisconsin Carbone Cancer Center
University of Wisconsin School of Medicine and Public Health
 
Joseph E. Kerschner, M.D.
Dean of the Medical School and Executive Vice President
Medical College of Wisconsin
 
Ming You, M.D., Ph.D.
Director, Medical College of Wisconsin Cancer Center
Senior Associate Dean for Cancer Research
Joseph F. Heil Jr. Professor of Oncogenesis
Professor, Pharmacology and Toxicology
Medical College of Wisconsin
 
Ann B. Nattinger, M.D., M.P.H.
Professor, Division Chief
General Internal Medicine
Lady Riders Breast Cancer Research Professor
Medical College of Wisconsin
 
James P. Thomas, M.D., Ph.D.
Associate Director, Translational Research
Medical Director, Clinical Trials Office
Section Head, Solid Tumor Oncology
Medical College of Wisconsin
 
Tracy Kelly, M.D.
Assistant Professor of Radiation Oncology
Medical College of Wisconsin
 
Carmen Bergom, M.D., Ph.D.
Assistant Professor of Radiation Oncology
Medical College of Wisconsin
 
Mary Beth Gonyo, M.D.
Associate Professor of Radiology
Chief, Section of Breast Imaging
Medical College of Wisconsin
 
Yee Chung Cheng, M.D.
Associate Professor Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
 
Christopher Chitambar, M.D.
Professor of Medicine
Director, Hematology and Oncology Fellowship Program
Medical College of Wisconsin
 
J. Douglas Rizzo, M.D., M.S.
Professor of Medicine
Cancer Service Line Director
Froedtert and the Medical College of Wisconsin
 
Douglas B. Evans, M.D.
Professor and Chair
Department of Surgery
Medical College of Wisconsin
 
Amanda L. Kong, M.D., M.S.
Associate Professor
Division of Surgical Oncology
Medical College of Wisconsin
 
Miraj Shah-Khan, M.D.
Assistant Professor
Division of Surgical Oncology
Medical College of Wisconsin
 
Paula M. Termuhlen, M.D.
Professor
Division of Surgical Oncology
Medical College of Wisconsin
 
Tina W.F. Yen, M.D., M.S.
Associate Professor
Division of Surgical Oncology
Chief, Breast/Endocrine Service
Medical College of Wisconsin
 
Alonzo P. Walker, M.D.
Ruth Teske Professor of Surgical Oncology
Senior Associate Dean for Faculty Affairs and Diversity
Medical College of Wisconsin
All persons in control of content have NO relevant relationships to disclose.
 

In accordance with the ACCME® standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved:

PresenterCompanyRole
Charles M. Balch, M.D.
Professor of Surgery
Division of Surgical Oncology
Department of Surgery
University of Texas Southwestern Medical Center
Merck, Amgen, NovartisConsultant, Honoraria
Funda Meric-Bernstam, M.D.
Chair, Department of Investigational Cancer Therapeutics
Medical Director, Khalifa Institute for Personalized Cancer Therapy
Professor, Department of Surgical Oncology
Division of Surgery
The University of Texas M. D. Anderson Cancer Center
Novartis, AstraZeneca, Taiho, Genentech, Roche Diagnostics, Sysmex

Research Support, Consultant and Honoraria

Elizabeth A. Mittendorf, M.D., Ph.D.
Associate Professor of Surgery
Department of Surgical Oncology
Division of Surgery
The University of Texas M. D. Anderson Cancer Center
Galena Biopharmark, Antigen Express, NorwellPrincipal Investigator
 
 
 

Available Credit

  • 3.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 3.50 Hours of Participation
    Hours of Participation credit.

Accreditation Period

Course opens: 
10/01/2014
Course expires: 
12/31/2014

Price

Cost:
$0.00
Please login or register to take this course.